Subependymal giant cell astrocytoma

Area of Science:

• Neuro-oncology
• Pediatric Neurosurgery
• Genetics of Neurological Disorders

Background:

• Subependymal giant cell astrocytomas (SEGAs) are WHO grade I tumors.
• SEGAs are intraventricular tumors often associated with tuberous sclerosis complex (TSC).
• These tumors can cause obstructive hydrocephalus.

Observation:

• This study presents a series of three cases of SEGAs.
• The cases highlight the typical presentation and management of these tumors.
• Clinical data and outcomes for each case were reviewed.

Findings:

• SEGAs are characterized by slow growth and a low-grade malignancy (WHO grade I).
• The primary treatment modality for SEGAs is surgical resection.
• Recurrences are rare, and the long-term prognosis following resection is excellent.

Implications:

• Early diagnosis and surgical intervention are crucial for managing obstructive hydrocephalus caused by SEGAs.
• Understanding the association with tuberous sclerosis complex aids in patient identification and management.
• The excellent prognosis underscores the effectiveness of surgical management for SEGAs.